Blackhawk Growth Corp
  • Home
  • About Us
  • Investors
      • Back
      • Stock Info
      • Capital Structure
      • Media
      • Corporate Presentation
      • Financial Statements
  • Investments
      • Back
      • Mindbio Therapeutics
      • Digital Mind Technologies
      • TERP Wholesale LLC
      • Trip Pharma
      • Sac Pharma
      • NuWave
      • Spaced Food
      • Noble Hemp
      • Medigen + TBG
  • News
      • Back
      • 2023
      • 2022
      • 2021
      • 2020
  • Contact
banner blackh
 

NEWS RELEASES

CSE:BLR | Frankfurt: 0JJ | US-OTC:BLRZF

  • 2023
  • 2022
  • 2021
  • 2020
List of articles in category 2022 News
Title Created Date
Dec 19 Blackhawk Growth's Spaced Food To Launch In Canada's Largest Market


Dec 02 Blackhawk Growth Receives Court Approval to Hold Special Meeting on December 22nd 2022 to Approve Mindbio Therapeutics Spinout


Nov 07 Blackhawk Growth Announces Shareholder Meeting for December 22, 2022 to Vote on the Spin-Out of Mindbio Therapeutics


Nov 04 Blackhawk's Mindbio Reveals Positive Data From Phase 1 Randomised Double-Blind Placebo Controlled Clinical Trials Microdosing LSD In 80 Healthy Participants


Oct 28 Blackhawk Growth to Reprofile Existing Credit Facility and Add Additional $2 Million Dollar Facility


Sep 28 BLACKHAWK's Mindbio Announces Phase 2A/B Clinical Trials Microdosing LSD in Major Depressive Disorder Submitted for Ethics & Regulatory Approval


Sep 22 BLACKHAWK's Mindbio Nominated for Company of the Year by Industry Peers as it Prepares for Phase 2 Clinical Trials


Sep 15 Blackhawk's MindBio Therapeutics Announces Reveal Date for Presentation of Phase 1 Clinical Trial Data


Aug 29 Blackhawk Growth's Spaced Food Manufacturing Partner Completes Development of Spaced Food Edibles; Prepares for Commercial Production


Aug 09 Blackhawk Growth Sets AGM Date and Provides Corporate Update


Jul 25 Blackhawk's Mindbio Therapeutics Announces Research Collaborators at University of Auckland Receive Grant Funding of $1.44 Million for LSD Microdosing Trials in Major Depressive Disorder


Jun 16 Blackhawk's Terp Wholesale LLC Reports Unaudited Cdn$1,644,043 in Gross Revenue for First Five Months Ended May 31st, 2022


Jun 06 Blackhawk Appoints Justin Hanka as Chairman of The Board


May 30 Blackhawk Growth Files Quarter Ended March 31, 2022 Financials and Reports Increase in Value of its Portfolio by 8.8% Quarter Over Quarter


May 24 Blackhawk's Terp Wholesale LLC Expands Facility, Launches Retail Delivery


May 11 Blackhawk's Mindbio Therapeutics Accelerates Global Communications Expansion Ahead of Phase 2 Clinical Trials


May 03 Blackhawk's MindBio Therapeutics Announces Completion of World First Phase 1 Microdosing Clinical Trial


Apr 28 Blackhawk Growth Closes Investment in Blum Distributors


Apr 19 BLACKHAWK GROWTHS Blum Distributors Expands Facility and Starts to Fulfill Applied Myco Order


Apr 06 BLACKHAWK GROWTH to Acquire Mycology Supplier and Cultivator - Blum Distributors


Apr 04 Blackhawk's MindBio Therapeutics Enters its 80th and Final Patient into Phase 1 Clinical Trials and Provides Update for MindBio Spinout


Mar 31 Blackhawk Growth's Spaced Food Adds New Flavours and Signs Partnership Agreement with Gaia Grow's Canadian Cannabis Laboratory Tru Extracts for Manufacturing of Blackhawk's Spaced Food Products


Mar 15 Blackhawks Mindbio Therapeutics Announces Investment in Health Research Platform Quantified Citizen, a Health Technology Company Disrupting and Decentralizing Clinical Research


Mar 11 Blackhawk Growth Closes Investment in Stable Foods


Mar 10 Blackhawk's MindBio Therapeutics Invests NZ$2.3 Million to Fast Track Psychedelic Microdosing Phase 2 Clinical Trials


Mar 08 Blackhawk's MindBio Therapeutics Announces Platinum Sponsorship of Plant Medicine Week in Malta


Feb 28 Blackhawk Growth to Acquire Remaining 49% of NuWave Foods; NuWave Foods Changes Name to Stable Foods


Feb 17 Blackhawk Subsidiary Digital Mind Technology Starts Phase 1 Development of Digital Therapeutic Platform and is on Track for Completion in Q2, 2022


Feb 03 Blackhawk Publishes MindBio Therapeutics Investor Presentation & Q&A Event on Website


Feb 01 Blackhawk CEO Frederick Pels and MindBio Therapeutics Co-Founder Justin Hanka Will Lead Investor Presentation and Q&A Session Wednesday, February 2nd at 3pm Pacific Standard Time


Jan 26 Blackhawk Launches New Website, Corporate Presentation and Engages Investor Relations Professional to Expand Outreach


Jan 24 Blackhawk's MindBio Therapeutics Ahead of Schedule to Complete Phase 1 Clinical Trial Microdosing of Psychedelic Medicines and Provides Updates on Spinout Process


Jan 17 Blackhawk's MindBio Therapeutics to Develop Psychedelic Medicine in Microdoses Ready for Commercial Use to Treat Major Depressive Disorder


Jan 12 Blackhawk’s TERP Wholesale LLC Receives State-Issued Micro-Business License Allowing for Retail Delivery


Jan 06 Blackhawk’s TERP Wholesale LLC Reports Unaudited $2,503,133 in Gross Revenue for Nine Months Ended September 30th, 2021


Jan 04 Blackhawk’s MindBio Therapeutics to Develop Proprietary Drug Delivery Technology for Psychedelic Medicines


Blackhawk Growth Corp
  • Home
  • About Us
  • Investors
  • Investments
  • News
  • Contact
© Copyright - 2023 Blackhawk Growth Corp. | Website by Sandman Media Inc.